Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Efficacy and safety of Androgen Deprivation Therapy (ADT) combined with modified docetaxel chemotherapy versus ADT combined with standard docetaxel chemotherapy in patients with metastatic castration-resistant prostate cancer: study protocol for a multicentre prospective randomized controlled trial

Fig. 1

Flow chart of the study. ADT: Androgen deprivation therapy; PSA: Prostate-specific antigen; QoL: Quality of life; CT: Computed tomography; MRI: Magnetic resonance imaging

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us